Pirronti T, Macis G, Sallustio G, Minordi L M, Granone P, Vecchio F M, Marano P
Istituto di Radiologia, Università Cattolica del Sacro Cuore, Roma.
Radiol Med. 2000 May;99(5):340-6.
To evaluate the role of CT in identifying other morphological signs of metastatic lymph node involvement from non small cell bronchogenic carcinoma. This is done to improve N staging, a critical step in this disease. In fact, since diameter is the only criterion used to distinguish normal form abnormal lymph nodes, medistinal CT only has 80% diagnostic accuracy.
137 patients with known or suspected lung cancer were examined with Helical CT during early and late arterial phases (2 min delay, 3 mm thickness, 5 mm interslice gap) to depict node characteristics. Mediastinal lymph nodes, located according to the American Thoracic Society mapping, were considered normal when they were not visible or, if visible, less than 1 cm in diameter and of homogeneous density; lymph nodes over 1 cm in diameter and homogeneous density were considered reactive. A lymph node was considered metastatic when, independent of size, the following signs were found: central hypodensity; hyperdense thin/thick rim, with nodules within; hyperdense strands or diffuse hyperdensity in perinodal adipose tissue. The tumor site was also considered.
Seventy patients were excluded because they were inoperable. Sixty-five of the remaining 67 patients were operated on, 1 underwent mediastinoscopy and another one mediastinoscopy followed by surgery. Based on the above CT signs, 46 patients were staged as N0, 61 as N1 and 15 as N2. In 44/46 N0 patients there was agreement between anatomical and pathologic findings; 3 of the 44 patients had lymph nodes over 1 cm in diameter and with homogeneous density. Micrometastases to mediastinal lymph nodes (N2) were found at histology in 2/46 patients (CT false negatives). In the 6 N1 and the 15 N2 patients there was complete agreement between anatomical and pathologic findings; in particular, 9 N2 patients had lymph nodes less than 1 cm in diameter with signs of metastasis and 4 had lymph nodes over 1 cm in diameter with signs of metastasis and 2 had lymph nodes either over or less than 1 cm. In all N2 patients the tumor histotype and the mediastinal location were also considered relative to the lesion site.
A closer correlation was found with node morphology and density than with size. Indeed, CT sensitivity, specificity and diagnostic accuracy were 97, 100 and 97%, respectively, for the former versus 52, 93 and 77% for the latter. Adenocarcinoma was the predominant histotype (70.5%) in N2 patients. Metastases to node region 4 were predominant in right upper lobe carcinomas while node region 5 was predominant in left upper lobe lesions.
Other criteria can be associated with size to improve CT diagnostic accuracy in N staging. Technique optimization plays a major role particularly in the late, thin slice, examination phase.
评估CT在识别非小细胞支气管肺癌转移性淋巴结受累的其他形态学征象中的作用。这样做是为了改进N分期,这是该疾病的关键步骤。事实上,由于直径是用于区分正常淋巴结与异常淋巴结的唯一标准,纵隔CT的诊断准确率仅为80%。
对137例已知或疑似肺癌患者在动脉早期和晚期(延迟2分钟,层厚3mm,层间距5mm)进行螺旋CT检查,以描绘淋巴结特征。根据美国胸科学会的图谱定位纵隔淋巴结,当淋巴结不可见或直径小于1cm且密度均匀时,视为正常;直径大于1cm且密度均匀的淋巴结视为反应性淋巴结。当发现以下征象时,无论淋巴结大小,均视为转移性淋巴结:中央低密度;高密度薄/厚边缘,内部有结节;高密度条索或淋巴结周围脂肪组织弥漫性高密度。同时考虑肿瘤部位。
70例患者因无法手术而被排除。其余67例患者中,65例接受了手术,1例接受了纵隔镜检查,另1例先接受纵隔镜检查后进行了手术。根据上述CT征象,46例患者分期为N0,61例为N1,15例为N2。在44/46例N0患者中,解剖学和病理学结果一致;44例患者中有3例淋巴结直径大于1cm且密度均匀。组织学检查发现2/46例患者纵隔淋巴结有微转移(CT假阴性)。在6例N1和15例N2患者中,解剖学和病理学结果完全一致;特别是,9例N2患者淋巴结直径小于1cm但有转移征象,4例淋巴结直径大于1cm且有转移征象,2例淋巴结直径大于或小于1cm。在所有N2患者中,还考虑了肿瘤组织学类型和纵隔位置与病变部位的关系。
发现与淋巴结形态和密度的相关性比与大小的相关性更紧密。事实上,前者的CT敏感性、特异性和诊断准确率分别为97%、100%和97%,而后者分别为52%、93%和77%。腺癌是N2患者中主要的组织学类型(70.5%)。右上叶癌转移至第4组淋巴结为主,左上叶病变转移至第5组淋巴结为主。
可将其他标准与大小相结合,以提高CT在N分期中的诊断准确率。技术优化尤其在晚期薄层检查阶段起着重要作用。